Pfizer Reaches $42.9M Accord With States In Marketing Row

Law360, Washington (December 12, 2012, 6:45 PM EST) -- Pfizer Inc. on Wednesday agreed to pay $42.9 million to settle 33 states' claims that the pharmaceutical giant used misleading and fraudulent marketing and sales tactics for its antibiotic Zyvox and seizure medication Lyrica, the states announced.

According to the attorneys general, Pfizer falsely promoted Zyvox as a superior antibiotic to vancomycin for some infections, despite regulator warnings and a lack of clinical evidence supporting the marketing claims. The company also allegedly promoted Lyrica for off-label treatments, including diabetic peripheral neuropathy and as an adjunct treatment...
To view the full article, register now.